Ramucirumab/Docetaxel Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C136285
A chemoimmunotherapy regimen consisting of ramucirumab and docetaxel that is used for the treatment of non-small cell lung cancer (NSCLC). [ ]
Term info
Label
Ramucirumab/Docetaxel Regimen
Synonyms
- Cyramza/Docetaxel Regimen
- Ramucirumab-Docetaxel
- Ramucirumab-Docetaxel Regimen
- Ramucirumab/Docetaxel
- Ramucirumab/Docetaxel Regimen
Subsets
NCIT_C160952, NCIT_C160950
Contributing Source
NCCN
NCI META CUI
CL523596
Preferred Name
Ramucirumab/Docetaxel Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C136285